Engineered Endo-α-GalNAcase for O-Glycan Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing O-linked glycans are limited by the lack of enzymatic means to release these glycans intact, relying on chemical methods which are not as effective as desired for detailed structural analysis, and existing endo-α-GalNAcases have narrow substrate specificity.
Innovation Solution
A family of polypeptides with endo-α-N-acetylgalactosaminidase activity, characterized by specific amino acid sequences and lacking carbohydrate-binding domains, capable of cleaving Core 1 and Core 3 O-linked glycans, providing a broad substrate specificity and enabling the release of O-glycans from glycoproteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chemical methods (β-elimination or mild hydrazinolysis) are used to release O-linked glycans, then O-glycans can be released from glycoproteins, but the structural analysis precision and integrity are insufficient compared to enzymatic methods
Solution Approach 1:
The patent modifies the substrate specificity parameters of endo-α-GalNAcase enzymes through mutagenesis and selection processes, transforming them from narrow specificity (acting only on Galβ1,3GalNAc) to broad specificity (acting on Core 1 and Core 3 O-linked glycans). This parameter change enables enzymatic release of diverse O-glycan structures with high precision while maintaining versatility across different glycoprotein substrates.
2Adaptability or versatility
If existing endo-α-GalNAcases are used, then some O-linked glycans can be cleaved, but the substrate specificity is narrow and limited to α-linked disaccharide Galβ1,3GalNAc
Solution Approach 1:
The patent creates universal endo-α-GalNAcase enzymes that can perform multiple functions: cleaving Core 1 O-linked glycans (Galβ1,3GalNAc), Core 3 O-linked glycans (GlcNAcβ1,3GalNAc), and various disaccharide substrates. This multi-functionality is achieved by engineering the active site to accommodate different glycan structures while maintaining high catalytic efficiency for each substrate type.
3Reliability
If chemical release methods are used, then O-glycans can be obtained, but the integrity and sensitivity for detailed structural analysis are compromised
Solution Approach 1:
The patent replaces chemical release mechanisms (β-elimination, hydrazinolysis) with enzymatic cleavage mechanisms. The engineered endo-α-GalNAcase enzymes provide specific catalytic activity that cleanly releases O-linked glycans from glycoproteins under mild conditions, preserving glycan integrity and enabling sensitive structural analysis through techniques like mass spectrometry and NMR.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These polypeptides facilitate the sensitive and specific analysis of O-linked glycans, offering a powerful tool for structure-function correlations and potential applications in biomedical research and diagnostics.
Implementation Method 1
endo-α-N-acetylgalactosaminidase (endo-α-GalNAcase), also called O-glycosidase activity
Implementation Method 2
a polypeptide member is provided that has endo-α-N-acetylgalactosaminidase (endo-α-GalNAcase), also called O-glycosidase activity
Data Source
AI summary
Methods and compositions have been described that relate to a newly identified polypeptide family wherein each member has O-glycosidase activity and specified sequence characteristics. This family of enzymes can be used for example for cleaving O-linked glycans and for synthesis of neoglycopeptides or neoglycoproteins.